Literature DB >> 8154587

Characterization of humanized anti-TAC, an antibody directed against the interleukin 2 receptor, using electrospray ionization mass spectrometry by direct infusion, LC/MS, and MS/MS.

D A Lewis1, A W Guzzetta, W S Hancock, M Costello.   

Abstract

Characterization of a humanized monoclonal antibody (Hu-anti-TAC) directed against a surface protein expressed on T-lymphocytes was performed with an electrospray mass spectrometer. Capillary reversed-phase liquid chromatography (LC)/mass spectrometry (MS) and direct infusion MS were utilized along with tandem MS/MS analysis to confirm the sequence and to determine the sources of heterogeneity in Hu-anti-TAC. The MS analysis was performed on disulfide-reduced and trypsin-digested samples of the antibody. Two forms of diantennary carbohydrate structures were identified and found to be consistent with those reported for the human IgG1 framework. The analysis demonstrated that the N-terminus was modified by conversion of a glutamine residue to pyroglutamic acid. Another source of heterogeneity was the partial removal of the C-terminal lysine residue and was confirmed by mass calculations of tryptic peptides followed by MS/MS sequencing. This study demonstrates that the high sensitivity of electrospray mass spectrometry when combined with capillary chromatography can allow detailed characterization of microgram samples of high molecular weight proteins such as antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8154587     DOI: 10.1021/ac00077a003

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  12 in total

Review 1.  Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Trap for MAbs: characterization of intact monoclonal antibodies using reversed-phase HPLC on-line with ion-trap mass spectrometry.

Authors:  John C Le; Pavel V Bondarenko
Journal:  J Am Soc Mass Spectrom       Date:  2005-03       Impact factor: 3.109

3.  Structural characterization of a recombinant monoclonal antibody by electrospray time-of-flight mass spectrometry.

Authors:  Lintao Wang; Godfrey Amphlett; John M Lambert; Walter Blättler; Wei Zhang
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

4.  Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry.

Authors:  Lintao Wang; Godfrey Amphlett; Walter A Blättler; John M Lambert; Wei Zhang
Journal:  Protein Sci       Date:  2005-08-04       Impact factor: 6.725

5.  Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer.

Authors:  Pavel V Bondarenko; Tonya P Second; Vlad Zabrouskov; Alexander A Makarov; Zhongqi Zhang
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-28       Impact factor: 3.109

6.  Characterization of mouse switch variant antibodies by matrix-assisted laser desorption ionization mass spectrometry and electrospray ionization mass spectrometry.

Authors:  S Akashi; K Noguchi; R Yuji; U Tagami; K Hirayama; K Kato; H Kim; K Tokioka; I Shimada; Y Arata
Journal:  J Am Soc Mass Spectrom       Date:  1996-08       Impact factor: 3.109

7.  Characterization of large, heterogeneous proteins by electrospray ionization-mass spectrometry.

Authors:  L Q Huang; A Paiva; R Bhat; M Wong
Journal:  J Am Soc Mass Spectrom       Date:  1996-12       Impact factor: 3.109

Review 8.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

9.  Optimization of reversed-phase peptide liquid chromatography ultraviolet mass spectrometry analyses using an automated blending methodology.

Authors:  Asish B Chakraborty; Scott J Berger
Journal:  J Biomol Tech       Date:  2005-12

10.  Physicochemical and biological characterization of 1E10 anti-idiotype vaccine.

Authors:  Yoan J Machado; Yamilet Rabasa; Raquel Montesinos; José Cremata; Vladimir Besada; Dasha Fuentes; Adolfo Castillo; Kathya R de la Luz; Ana M Vázquez; Martin Himly
Journal:  BMC Biotechnol       Date:  2011-11-22       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.